CN115838665A - Enterobacter strain TCD1-1 T And uses thereof - Google Patents
Enterobacter strain TCD1-1 T And uses thereof Download PDFInfo
- Publication number
- CN115838665A CN115838665A CN202211437811.9A CN202211437811A CN115838665A CN 115838665 A CN115838665 A CN 115838665A CN 202211437811 A CN202211437811 A CN 202211437811A CN 115838665 A CN115838665 A CN 115838665A
- Authority
- CN
- China
- Prior art keywords
- tcd1
- strain
- medium
- nitrate
- ferrous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000588914 Enterobacter Species 0.000 title claims abstract description 43
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 claims abstract description 33
- 229910002651 NO3 Inorganic materials 0.000 claims abstract description 28
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims abstract description 28
- 238000000034 method Methods 0.000 claims abstract description 23
- 230000003647 oxidation Effects 0.000 claims abstract description 23
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 23
- 230000009467 reduction Effects 0.000 claims abstract description 20
- 238000004321 preservation Methods 0.000 claims abstract description 17
- MMDJDBSEMBIJBB-UHFFFAOYSA-N [O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[NH6+3] Chemical compound [O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[NH6+3] MMDJDBSEMBIJBB-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229910001448 ferrous ion Inorganic materials 0.000 claims abstract description 12
- 239000002609 medium Substances 0.000 claims description 38
- 239000000243 solution Substances 0.000 claims description 30
- 239000001963 growth medium Substances 0.000 claims description 22
- 229920001817 Agar Polymers 0.000 claims description 10
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000008272 agar Substances 0.000 claims description 10
- 239000006285 cell suspension Substances 0.000 claims description 9
- 239000011782 vitamin Substances 0.000 claims description 8
- 229940088594 vitamin Drugs 0.000 claims description 8
- 229930003231 vitamin Natural products 0.000 claims description 8
- 235000013343 vitamin Nutrition 0.000 claims description 8
- 239000007853 buffer solution Substances 0.000 claims description 7
- 239000011573 trace mineral Substances 0.000 claims description 7
- 235000013619 trace mineral Nutrition 0.000 claims description 7
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 4
- -1 nitrate ions Chemical class 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- AFQIYTIJXGTIEY-UHFFFAOYSA-N hydrogen carbonate;triethylazanium Chemical compound OC(O)=O.CCN(CC)CC AFQIYTIJXGTIEY-UHFFFAOYSA-N 0.000 claims description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 14
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract description 12
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 9
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 abstract description 6
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 239000001272 nitrous oxide Substances 0.000 abstract description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 29
- 229910052742 iron Inorganic materials 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 12
- 230000012010 growth Effects 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000008367 deionised water Substances 0.000 description 10
- 229910021641 deionized water Inorganic materials 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 108020004465 16S ribosomal RNA Proteins 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 230000008569 process Effects 0.000 description 7
- 241001482378 Enterobacter tabaci Species 0.000 description 6
- 241001493237 Enterobacter mori Species 0.000 description 5
- 241000209094 Oryza Species 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- 239000008186 active pharmaceutical agent Substances 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 108700039887 Essential Genes Proteins 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000007640 basal medium Substances 0.000 description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 102100030497 Cytochrome c Human genes 0.000 description 3
- 108010075031 Cytochromes c Proteins 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- 241000997535 Enterobacter asburiae JCM 6051 Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 3
- 235000013980 iron oxide Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- 241000186361 Actinobacteria <class> Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 101100499417 Chlamydia pneumoniae dnaA1 gene Proteins 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 238000007900 DNA-DNA hybridization Methods 0.000 description 2
- 241000881810 Enterobacter asburiae Species 0.000 description 2
- 241000043309 Enterobacter hormaechei Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 2
- 238000007476 Maximum Likelihood Methods 0.000 description 2
- 101100038261 Methanococcus vannielii (strain ATCC 35089 / DSM 1224 / JCM 13029 / OCM 148 / SB) rpo2C gene Proteins 0.000 description 2
- 108090000913 Nitrate Reductases Proteins 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 241000366197 Paludicola Species 0.000 description 2
- 102000010562 Peptide Elongation Factor G Human genes 0.000 description 2
- 108010077742 Peptide Elongation Factor G Proteins 0.000 description 2
- 238000001237 Raman spectrum Methods 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 229940089837 amygdalin Drugs 0.000 description 2
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000009087 cell motility Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 150000004683 dihydrates Chemical class 0.000 description 2
- 101150020338 dnaA gene Proteins 0.000 description 2
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 101150015255 rplB gene Proteins 0.000 description 2
- 101150085857 rpo2 gene Proteins 0.000 description 2
- 101150090202 rpoB gene Proteins 0.000 description 2
- 238000004626 scanning electron microscopy Methods 0.000 description 2
- 239000010865 sewage Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- QXJDESBAUIILLG-UHFFFAOYSA-N 1,2,3,3,4,4,4-heptafluoro-1-iodobut-1-ene Chemical compound FC(I)=C(F)C(F)(F)C(F)(F)F QXJDESBAUIILLG-UHFFFAOYSA-N 0.000 description 1
- VBUYCZFBVCCYFD-JJYYJPOSSA-N 2-dehydro-D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)C(O)=O VBUYCZFBVCCYFD-JJYYJPOSSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000711404 Avian avulavirus 1 Species 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- HEBKCHPVOIAQTA-IMJSIDKUSA-N L-arabinitol Chemical compound OC[C@H](O)C(O)[C@@H](O)CO HEBKCHPVOIAQTA-IMJSIDKUSA-N 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 108010048581 Lysine decarboxylase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- HDAJUGGARUFROU-JSUDGWJLSA-L MoO2-molybdopterin cofactor Chemical compound O([C@H]1NC=2N=C(NC(=O)C=2N[C@H]11)N)[C@H](COP(O)(O)=O)C2=C1S[Mo](=O)(=O)S2 HDAJUGGARUFROU-JSUDGWJLSA-L 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- DKXNBNKWCZZMJT-UHFFFAOYSA-N O4-alpha-D-Mannopyranosyl-D-mannose Natural products O=CC(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O DKXNBNKWCZZMJT-UHFFFAOYSA-N 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 102000052812 Ornithine decarboxylases Human genes 0.000 description 1
- 108700005126 Ornithine decarboxylases Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 1
- 101100397220 Rhodococcus sp. (strain AD45) isoH gene Proteins 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009603 aerobic growth Effects 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- GFHNAMRJFCEERV-UHFFFAOYSA-L cobalt chloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Co+2] GFHNAMRJFCEERV-UHFFFAOYSA-L 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229960003280 cupric chloride Drugs 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- FRKBLBQTSTUKOV-UHFFFAOYSA-N diphosphatidyl glycerol Natural products OP(O)(=O)OCC(OP(O)(O)=O)COP(O)(O)=O FRKBLBQTSTUKOV-UHFFFAOYSA-N 0.000 description 1
- TUANAMBRHOLYTH-UHFFFAOYSA-L disodium selenite pentahydrate Chemical compound O.O.O.O.O.[Na+].[Na+].[O-][Se]([O-])=O TUANAMBRHOLYTH-UHFFFAOYSA-L 0.000 description 1
- 230000022912 endospore formation Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000012851 eutrophication Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229960002413 ferric citrate Drugs 0.000 description 1
- 229960002089 ferrous chloride Drugs 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004687 hexahydrates Chemical class 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- CNFDGXZLMLFIJV-UHFFFAOYSA-L manganese(II) chloride tetrahydrate Chemical compound O.O.O.O.[Cl-].[Cl-].[Mn+2] CNFDGXZLMLFIJV-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- DLRVVLDZNNYCBX-ABXHMFFYSA-N melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-ABXHMFFYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 108010046778 molybdenum cofactor Proteins 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical group 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000013081 phylogenetic analysis Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000004224 potassium gluconate Substances 0.000 description 1
- 235000013926 potassium gluconate Nutrition 0.000 description 1
- 229960003189 potassium gluconate Drugs 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 108700022487 rRNA Genes Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- XMVONEAAOPAGAO-UHFFFAOYSA-N sodium tungstate Chemical compound [Na+].[Na+].[O-][W]([O-])(=O)=O XMVONEAAOPAGAO-UHFFFAOYSA-N 0.000 description 1
- WGRULTCAYDOGQK-UHFFFAOYSA-M sodium;sodium;hydroxide Chemical compound [OH-].[Na].[Na+] WGRULTCAYDOGQK-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The application provides a preservation number of CCTCC AB2016351 T Enterobacter strain TCD1-1 T Enterobacter strain TCD1-1 T Application in ferrous iron oxidation and nitrate nitrogen reduction and a method for ferrous iron oxidation and nitrate nitrogen reduction. Wherein the preservation number is CCTCC AB2016351 T Enterobacter strain TCD1-1 T By Enterobacter strain TCD1-1 T Can link the ferrous oxidation and the nitrate reduction under the anaerobic condition, and takes ferrous ions asElectron donor to reduce nitrate to nitrite and nitrous oxide (N) 2 O), nitric Oxide (NO), and nitrogen (N) 2 ) These compounds cause nitrogen loss.
Description
Technical Field
This application relates toAnd the technical field of microorganisms, in particular to an enterobacter strain TCD1-1 T And applications thereof.
Background
Nitrate-dependent iron oxidation process (NDFO) is a microbial-mediated process of coupling nitric acid reduction and iron oxidation, and nitrate-dependent iron oxidizing bacteria play an important role in the recycling of iron elements and the loss of nitrogen elements.
Disclosure of Invention
In view of the above, the present application aims to provide an Enterobacter strain TCD1-1 T And applications thereof.
In view of the above, the embodiment of the present application provides a preservation number of CCTCC AB2016351 T Enterobacter strain TCD1-1 T 。
The embodiment of the application also provides a preservation number of CCTCC AB2016351 T Enterobacter strain TCD1-1 T The application in ferrous oxidation and nitrate nitrogen reduction.
The embodiment of the application also provides a method for reducing ferrous oxide and nitrate, which adopts a preservation number of CCTCC AB2016351 T Enterobacter strain TCD1-1 T Ferrous iron oxidation and nitrate nitrogen reduction.
As can be seen from the foregoing, embodiments of the present application provide a collection number of CCTCC AB2016351 T Enterobacter strain TCD1-1 T And applications thereof. Enterobacter strain TCD1-1 provided in the examples of the present application T Can link the ferrous oxidation with the nitrate reduction under anaerobic condition, and reduce the nitrate into nitrite and nitrous oxide (N) by taking ferrous ions as electron donors 2 O), nitric Oxide (NO), and nitrogen (N) 2 ) The compounds cause the loss of nitrogen, and can reduce nitrate while oxidizing ferrous iron ecologically.
Drawings
In order to more clearly illustrate the technical solutions in the present application or the related art, the drawings needed to be used in the description of the embodiments or the related art will be briefly introduced below, and it is obvious that the drawings in the following description are only embodiments of the present application, and it is obvious for those skilled in the art that other drawings can be obtained according to these drawings without creative efforts.
FIG. 1a shows strain TCD1-1 T Scanning electron microscopy imaging of growth on R2A medium.
FIG. 1b shows strain TCD1-1 T Scanning electron microscopy imaging of growth on NDFO medium.
FIG. 2 molybdophosphoric acid-stained TCD1-1 T Two-dimensional TLC (thin layer chromatography) of polar lipid extracts of the strain. Wherein DPG is diphosphatidylglycerol; PE is phosphatidyl ethanolamine; PG is phosphatidyl glycerol; PL is a phospholipid; l1 and L2 are unknown lipids.
FIG. 3 is a schematic representation of a phylogenetic tree based on the adjacency (bootstrap values, 1000 repeats) of the 16S rRNA gene sequence.
FIG. 4 is a schematic diagram of a maximum likelihood (a) and minimum evolution (b) (bootstrap values, 1000 repeats) phylogenetic tree based on the 16S rRNA gene sequence.
FIG. 5 TCD1-1 in the culture Process T Schematic representation of the oxidation of ferrous iron by the strain in NDFO medium.
Fig. 6a is a bar graph of nitrate consumption during 4 days of culture for the experimental group and the first control group.
Fig. 6b is a bar graph of the consumption of ferrous iron during 4 days of culture for the experimental group and the first control group.
FIG. 6c shows strain TCD1-1 in the experimental group T Raman spectrum of iron shells on the cell surface after 96 hours of culture in NDFO medium.
Detailed Description
In order to make the objects, technical solutions and advantages of the present application more apparent, the present application is further described in detail below with reference to the accompanying drawings in combination with specific embodiments.
It should be noted that technical terms or scientific terms used in the embodiments of the present application should have a general meaning as understood by those having ordinary skill in the art to which the present application belongs, unless otherwise defined. The use of "first," "second," and similar terms in the embodiments of the present application do not denote any order, quantity, or importance, but rather the terms are used to distinguish one element from another. The word "comprising" or "comprises", and the like, means that the element or item listed before the word covers the element or item listed after the word and its equivalents, but does not exclude other elements or items. The terms "connected" or "coupled" and the like are not restricted to physical or mechanical connections, but may include electrical connections, whether direct or indirect. "upper", "lower", "left", "right", and the like are used merely to indicate relative positional relationships, and when the absolute position of the object being described is changed, the relative positional relationships may also be changed accordingly.
The embodiment of the application provides a preservation number of CCTCC AB2016351 T Enterobacter strain TCD1-1 T By Enterobacter strain TCD1-1 T Can link the ferrous oxidation with the nitrate reduction under anaerobic condition, and reduce the nitrate into nitrite and nitrous oxide (N) by taking ferrous ions as electron donors 2 O), nitric Oxide (NO), and nitrogen (N) 2 ) These compounds cause nitrogen loss.
Biological preservation Instructions
Enterobacter strain TCD1-1 T : classified name is enterobacter TCD1-1 T (Enterobacter yingtanensis sp.nov.TCD1-1 T ) Has been preserved in China Center for Type Culture Collection (CCTCC) at 19.8.18.1.5.the preservation Center address is China Center for Type Culture Collection, wuhan university, eight-channel 299 in Wuchang district, wuhan City, hubei province, and the preservation number is CCTCC AB2016351 T 。
The Enterobacter strain TCD1-1 T Has the following physiological and biochemical characteristics:
(1) The enterobacter strain TCD1-1 T Is a gram-negative bacterium;
(2) The Enterobacter strain TCD1-1 T The colony morphology in R2A and LB culture medium is white, the surface is smooth and convex, the width is 0.3-0.6 μm, and the length is 0.6-2.2 μm;
(3) The enterobacter strain TCD1-1 T In a scanning electron microscopeNo endospore formation, no cell motility during culture;
(4) The Enterobacter strain TCD1-1 T The growth temperature range is 4-60 ℃, and the optimal growth temperature is 30 ℃; the tolerance range of pH is 3-10, and the optimum pH value is 7.0; naCl tolerance ranges from 0-13% (w/v).
The embodiment of the application also provides a preservation number of CCTCC AB2016351 T Enterobacter strain TCD1-1 T The application in ferrous oxidation and nitrate nitrogen reduction.
The large accumulation of nitrate nitrogen such as nitrate in the water body can cause water body pollution, great threat to the survival of aquatic organisms, water body eutrophication and other problems. Iron ion (ferrion) with the symbol Fe 3+ It is the most stable ion of iron, has strong oxidizability, and is an important industrial agent. For example, ferric trichloride can be applied to metal etching, sewage treatment and the like. Therefore, the preservation number is CCTCC AB2016351 T Enterobacter strain TCD1-1 T Can provide an eco-friendly method for eliminating nitrate and oxidizing ferrous ions to generate iron ions.
The embodiment of the application also provides a method for reducing ferrous oxide and nitrate, which adopts a preservation number of CCTCC AB2016351 T Enterobacter strain TCD1-1 T Ferrous iron oxidation and nitrate nitrogen reduction.
In some embodiments, the method comprises:
s100, numbering the preservation number of CCTCC AB2016351 T Enterobacter strain TCD1-1 T Inoculating into the first culture medium, and culturing to plate.
S200, culturing the Enterobacter strain TCD1-1 after plate culture T Preparing a cell suspension, and inoculating the cell suspension in a second culture medium for ferrous oxidation and nitrate nitrogen reduction.
Wherein the first culture medium can be a solid medium, has a pH of 6.8-7.2, and comprises agar and NDFO medium (i.e., the second culture medium); the ratio of the mass of the agar to the volume of the NDFO medium is 18-22%, for example 20%. The second medium may be a liquid medium, pH 6.8-7.2, NDFO medium. As the first culture medium, it can be obtained by dissolving agar in a solid state into NDFO medium in a liquid state.
The NDFO culture medium is prepared by adding vitamin solution, microelement solution SL-10, selenite-tungstate solution, triethylamine bicarbonate buffer solution, ferrous ions and nitrate into a basic culture medium. Wherein the basal medium may comprise MgSO 4 ·7H 2 O、CaCl 2 ·H 2 O、NH 4 Cl and KH 2 PO 4 . In the first medium, the concentration ratio of ferrous ions to nitrate ions may be 1. The concentration of the ferrous ions is 9.5-10.5 mmol L -1 The concentration of the nitrate ion is 9.5-10.5 mmol L -1 。
The NDFO medium may be in liquid form and has a pH of 6.8-7.2. The specific component can be MgSO 4 ·7H 2 O(0.5gL -1 )、CaCl 2 ·H 2 O(0.1gL -1 )、NH 4 Cl(0.3gL -1 )、KH 2 PO 4 (0.6gL -1 ) Vitamin solution (1 ml L) -1 ) Trace element solution SL10 (1 ml L) -1 ) Selenite-tungstate solution (1 ml L) -1 ) Triethylamine Bicarbonate buffer Bicarbonate buffer (22 mmol L) -1 )、FeCl 2 (10mmol L -1 ) And NaNO 3 (10mmol L -1 )。
The vitamin solution may contain various vitamins, and the main components are shown in table 1 below. The trace element solution may contain a variety of trace elements, with the main composition as in table 2 below. The composition of the selenite-tungstate solution may be as shown in table 3 below.
TABLE 1 composition of vitamin solution
TABLE 2 composition of the microelement solutions
Composition (I) | Volume in solution of trace elements |
Hydrochloric acid 25% | 10ml |
FeCl (ferrous chloride tetrahydrate) 2 *4H 2 O | 1.5g |
Boric acid H 3 BO 3 | 30mg |
Manganese chloride (tetrahydrate) MnCl 2 *4H 2 O | 100mg |
CoCl (cobalt chloride hexahydrate) 2 *6H 2 O | 190mg |
NiCl (NiCl hexahydrate) 2 *6H 2 O | 24mg |
Cupric chloride (dihydrate) CuCl 2 *2H 2 O | 2mg |
Zinc chloride ZnCl 2 | 70mg |
Sodium molybdate (dihydrate) Na 2 MoO 4 *2H 2 O | 36mg |
Deionized water | 1000ml |
TABLE 3 composition of selenite-tungstate solution
NaOH sodium hydroxide | 0.4g |
Sodium selenite (pentahydrate) Na 2 SeO 3 *5H 2 O | 6mg |
Sodium tungstate (dihydrate) Na 2 WO 4 *2H 2 O | 8mg |
Deionized water | 1000.0ml |
The NDFO medium may be prepared by:
basal medium (MgSO) 4 ·7H 2 O、CaCl 2 ·H 2 O、NH 4 Cl and KH 2 PO 4 ) Aeration is carried out N 2 /CO 2 (80/20%) and autoclaved at 120 ℃ for 20 minutes. Mixing Vitamin solution, trace element solution SL10, Selenite-tungstate solution, bicarbonate buffer and FeCl 2 After filtration (0.22 μm) and sterilization, respectively, the cells were added to the basal medium.
In an anaerobic glove box (N) 2 :CO 2 :H 2 The NDFO medium was prepared by removing the formed precipitate by filtration (0.22 μm) in = 90.
The NDFO culture medium can be subpackaged, and each 20mL culture medium is added into a 50mL serum bottle and finally sealed.
In some embodiments, in step S100, the temperature in the plate culture conditions may be room temperature, and the anaerobic light-resistant culture is performed for 72h. Thus, TCD1-1 can be cultured T And (5) bacterial colonies.
In some embodiments, in step S200, the cultured colonies may be separated from the first medium by a sodium chloride solution (NaCl), washed with sterile, anaerobic deionized water, and resuspended in deionized water to obtain a cell suspension. OD of the cell suspension 600 The value may be 1.22.
In some embodiments, the temperature for ferrous oxidation and nitrate nitrogen reduction is room temperature, anaerobic and dark, and the time is 96-120h.
The technical solution of the present invention will be further described with reference to the following embodiments.
The experimental procedures in the following examples are conventional unless otherwise specified.
The test materials used in the following examples were purchased from a conventional biochemical reagent store unless otherwise specified.
EXAMPLE 1 preparation of second Medium (NDFO)
(1) MgSO (MgSO) 4 ·7H 2 O、CaCl 2 ·H 2 O、NH 4 Cl and KH 2 PO 4 Mixing to obtain 0.5gL -1 MgSO (2) of 4 ·7H 2 O、0.1gL -1 In (C) is 2 ·H 2 O、0.3gL -1 NH of 4 Cl and 0.6gL -1 KH of 2 PO 4 The mixed solution of (1) is 80%/20% N 2 /CO 2 Aerating, and autoclaving at 120 deg.C for 20 min to obtain basic culture medium.
(2) Mixing Vitamin solution, trace element solution SL10, selenite-tungstate solution, bicarbonate buffer and FeCl 2 After filtration (0.22 μm) and sterilization, the basal medium was added.
(3) Adding Bicarbonate buffer and FeCl 2 Then, in an anaerobic glove box (N) 2 :CO 2 :H 2 = 90) by filtration (0.22 μm). Subpackaging 20mL of culture medium to 50mL of serum bottles, and finally sealing the culture medium.
EXAMPLE 2 preparation of the first Medium
Agar was mixed with 20% by mass/volume of the NDFO medium obtained in example 1, and 80%/20% N was used 2 /CO 2 Aeration was performed and autoclaved at 120 ℃ for 20 minutes.
Example 3 accession number CCTCC AB2016351 T Enterobacter strain TCD1-1 T Separation and screening of
(1) In the anaerobic environment of rice soil, a large amount of Fe is generated in the processes of biological iron reduction and chemical iron reduction 2+ . Rice soil from Yingtan, jiangxi, china (116 ° 82'N,28 ° 2' E) was collected, which is rich in iron oxides but deficient in organic matter, a typical type of southern acidic red soil. 3g of rice soil was put into a 100mL serum bottle containing 50mL of oxygen-free sterilized water, then sealed with a butyl rubber stopper and fixed with an aluminum cap, and incubated at 25 ℃ for 2 hours in the dark at 120rpm to form a rice slurry.
(2) Using the slurry of rice as an inoculation source, 2mL of the slurry was added to a 50mL serum bottle containing 20mL of oxygen-free NDFO medium prepared in example 1, and the mixture was cultured in dark at 25 ℃ for 30 days.
(3) After 30 days of culture, brick red precipitates can be generated in the culture solution; the concentrate (10%) was transferred to fresh anaerobic NDFO medium and the process was repeated four times to obtain the final concentrate.
(4) The final enrichment was diluted in a gradient (1 ten thousand fold) and the resulting NDFO agar plates (i.e., prepared in example 2) were plated outFirst culture medium) was applied (10. Mu.L), and N was introduced in a volume ratio of 80/20% during the culture 2 /CO 2 Colonies were obtained under anaerobic conditions.
(5) Selecting a single bacterium colony, streaking the single bacterium colony on the NDFO agar plate, and separating to obtain a single bacterium TCD1-1 T 。
Example 4 accession number CCTCC AB2016351 T Enterobacter strain TCD1-1 T Identification of physiological and biochemical characteristics of
Reference strain E.tabaci CGMCC 1.15707 T ,E.mori CGMCC 1.10322 T ,E.hormaechei CGMCC 1.10608 T and E.asburiae JCM 6501 T Purchased from China microbial Culture Collection (CGMCC) and Japan Collection of Microorganisms (JCM), respectively.
4.1 morphological Observation
TCD1-1 T Colony morphology was examined after aerobic growth on R2A and LB agar plates. Gram reaction was tested using the 3% KOH method. The cell surface morphology was observed with a scanning electron microscope. TCD1-1 T The cell motility activity of (2) was observed on semi-solid R2A plates.
The results of the experiment are shown in FIGS. 1a and 1 b. Wherein, FIG. 1a shows strain TCD1-1 T Growth on R2A medium. FIG. 1b shows strain TCD1-1 T Growth on NDFO medium. The bacterial strain is gram-negative bacteria, is rod-shaped, and has white colony morphology, smooth surface, convex shape and no motility.
4.2 salt tolerance
The purified strain TCD1-1 T The cells were inoculated into R2A media containing NaCl at different ratios (0, 1.5, 3, 4.5, 6, 7.5, 9, 10, 11.5 and 13% w/v), respectively, monitored for two days in an aerobic environment, and growth was observed.
The results are shown in Table 4, in which reference numeral 1 denotes the accession number CCTCC AB2016351 T Enterobacter strain TCD1-1 T . Reference numeral 2 represents the reference strain E.hormaedei CGMCC 1.10608 T . The number 3 represents E.tabaci CGMCC 1.15707 T . Reference numeral 4 represents a reference strain E.mori CGMCC1.10322 T . Reference numeral 5 denotes the reference strain E.asburiae JCM 6051 T . Wherein "-" means present in<1% or not detected. "+" indicates that the corresponding property is present.
As can be seen from Table 4, the NaCl tolerance of this strain ranged from 0-13% (w/v).
TABLE 4 TCD1-1 T And comparing the physiological morphological characteristics of the strain and the kindred species.
4.3 Heat resistance
Purifying the strain TCD1-1 T Inoculated in R2A culture medium, respectively placed in different temperatures (4, 15, 20, 25, 30, 37, 50, 60 ℃), monitored for two days under aerobic environment, and observed for growth.
The results of the experiment are shown in table 4. As can be seen, the growth temperature range of the strain is 4-60 ℃, and the optimal growth temperature is 30 ℃.
4.4 acid resistance
In the R2A medium, the pH range (3, 4, 5, 6, 7, 8, 9 and 10) was adjusted by adding HCl or NaOH and monitored for 2 days in an aerobic environment, and the pH range of growth was investigated.
As shown in Table 4, the pH tolerance range of the strain was 3 to 10, and the optimum pH was 7.0.
4.5 carbon Source metabolizing Activity
In the API 20E test, the results show that the strain TCD1-1 T Glucose, mannitol, sorbitol, rhamnose, sucrose, melibiose, amygdalin, and arabinose can be utilized.
4.6 enzymatic Activity
In the API 20E test, the results show that the strain TCD1-1 T Has catalase, oxidase, O-nitrobenzene-beta-D-Galactopyranoside, arginine hydrolase, lysine decarboxylase, ornithine decarboxylase activity.
4.7 acid production
In the API 50CH assay, the results indicated that strain TCD1-1 T The acid production can be carried out using the following carbon sources: glycerol, L-arabitol, D-ribose, D-xylose, D-galactose, D-glucose, D-fructose, D-mannose, L-rhamnose, inositol, D-mannitol, D-sorbitol, methyl-alpha-D-glucopyranoside, N-acetylglucosamine, arbutin, trehalose/ferric citrate, salicin, cellobiose, D-maltose, D-lactose, D-melibiose, D-sucrose, D-trehalose, D-raffinose, amygdalin, D-lyxose, potassium gluconate and potassium 2-ketogluconate.
Example 5 accession number CCTCC AB2016351 T Enterobacter strain TCD1-1 T Identification of the bacterial species
5.1 chemical Classification identification
Fatty acids the fatty acid composition of the samples was analyzed using the full-automatic bacteria Identification system of the company shorolock, MIDI (micro Identification) in usa. The cells were analyzed for polar lipid mass spectra using thin plate biphasic chromatography (TLC). The major respiratory quinones were extracted from freeze-dried cells and analyzed by RP-HPLC.
The test results are shown in table 5. Wherein reference numeral 1 denotes a preservation number of CCTCC AB2016351 T Enterobacter strain TCD1-1 T . Reference numeral 2 represents the reference strain E.hormaedei CGMCC 1.10608 T . The number 3 represents E.tabaci CGMCC 1.15707 T . Reference numeral 4 represents a reference strain E.mori CGMCC1.10322 T . Reference numeral 5 denotes the reference strain E.asburiae JCM 6051 T . Wherein "-" means present in<1% or not detected. "+" indicates that there is a corresponding capability.
As can be seen, TCD1-1 T The main fatty acid of (B) is C 16:0 (33.05%)、C 17:0 cyclo (19.82%) and C 18:1 w7c (17.47%), as shown in Table 5. Similar to closely related strains, but the content of each fatty acid is greatly different, especially C 14:0 2-OH C 13:0 、C 15:1 isoH/C 13:0 3OH、C 17:0 cyclo w8c、C 17:0 And C 13:0 See table 5.TCD1-1 T The polar lipids of the cells consist of DPG, PE, PG, PL, L1 and L2, as shown in FIG. 2, and the major respiratory quinone is Q-8, as shown in Table 4. Strain TCD1-1 T The cells of (a) express oxidase and catalase as shown in Table 4. Except that E.asburiae JCM 6051 T In addition to being negative for rhamnose and melibiose, strain TCD1-1 T The closely related strains showed almost the same pattern in the API 20E and API 50CH systems as shown in table 4.
TABLE 5 Strain TCD1-1 T And cellular fatty acid composition of closely related species thereof.
TABLE 6 TCD1-1 T Similarity of housekeeping genes with their cognate species.
5.2 genetic characteristics
DNA extraction was performed using the FastDNA Spin kit (MP Biomedical, france). Universal primer pair (27F and 1492R) for amplifying TCD1-1 T 16S rRNA gene of the strain. 16S rRNA gene alignments between strains were performed by EzTaxon server. Phylogenetic trees were constructed using the adjacency method (bootstrap values, 1000 replicates; calculated using MEGA version 7.0) and the aligned sequences were analyzed by CLUSTAL X. Amplification of TCD1-1 T Housekeeping genes (dnaA, fusA, rplB and rpoB) of the strains and the reference strains. Enterobacter strain TCD1-1 T GenBank accession numbers of 16S rRNA and housekeeping gene sequences of (9) are KY628806 and SRR15667831-15667850. As shown in fig. 3 and 4. Wherein, FIG. 3 is based on 16SPhylogenetic Tree of adjacency (Bootstrap value, 1000 repeats) of rRNA Gene sequences, indicating TCD1-1 T The strain is in a phylogenetic position in the relevant species. The scale bar in the figure represents 100 nucleotides. The sequence of Propionimonas paludicola belonging to actinomycetes was used as the exocolony. FIG. 4 is a maximum likelihood (a) and minimum evolution (b) (bootstrap values, 1000 repeats) phylogenetic tree based on the 16S rRNA gene sequence, showing strain TCD1-1 T At a phylogenetic position in the relevant species. The scale bar in the figure represents 100 nucleotides. The sequence of Propionimonas paludicola belonging to actinomycetes was used as the exocolony.
As can be seen, phylogenetic analysis based on the 16S rRNA gene showed that strain TCD1-1 T Belonging to the genus Enterobacter.
Strain TCD1-1 T Strain E.tabaci CGMCC 1.15707 related to its phylogeny T ,E.mori CGMCC 1.10322 T ,E.hormaechei CGMCC 1.10608 T ,E.asburiae JCM6501 T The sequence similarity between them was 99.37%,99.30%,98.52%,97.89%, respectively, as shown in table 4. Strain TCD1-1 T The DNA G + C content of (2) was 57mol%, which is close to that of phylogenetically related strains, as shown in Table 4. TCD1-1 T And E.hormaedei CGMCC 1.10608 T 、E.tabaci CGMCC 1.15707 T ;E.mori CGMCC 1.10322 T And e.asbushiae JCM 6051 T The DNA-DNA hybridization values of (1) were 57.75%, 72.62%, 50.86% and 60.20%, respectively, as shown in Table 4. Based on a 70% threshold for DNA-DNA hybridization for species division, TCD1-1 is recommended T May be used as E.tabaci CGMCC 1.15707 T A subspecies of (1). To further improve resolution, for TCD1-1 T The similarity between housekeeping genes (including dnaA, fusA, rplB and rpoB) with their closely related strains was analyzed, and the results showed that the similarity between them was 90.12 to 96.01%, as shown in Table 6, demonstrating TCD1-1 T The genomic difference from its closely related strain indicates TCD1-1 T Is a new species belonging to enterobacteria.
5.3 genomic Properties
TCD1-1 T Genome sequencing in Meiji (China)Sea) on the Hiseq 4000 platform (2X 150 bp). The Metawrap package (1.2.1) was used to analyze the assembly of the original genome. Briefly, the genome was further examined, trimmed and assembled using Megahit (1.1.3) at the default setting. The scaffold sequences of 1000bps or more were binned into refined genomic bins using a combination of conct (1.0.0), maxBin2 (2.2.6) and metaBAT2 (2.12.1). To improve bin quality, TCD1-1 T Respectively using short read mappers BWA (0.7.17) and SPAdes (3.13.0). TCD1-1 T The degree of contamination and integrity of the genome was assessed by CheckM (1.0.12). The protein coding region was predicted using prodigan software with the "-p meta" option (version 2.6.3). TCD1-1 pairs using the KEGG database (BlastKOALA), interProScan (5.44-79.0), eggNOG-mapper (5.0.0), diamond (0.9.22) and NCBI-nr database (10 month search 2021, E value. Ltoreq.1E-5) in combination T The genome of (a) is annotated.
Strain TCD1-1 T The genome length of (a) is 4557964bp, and there are 4311 protein-coding genes in total, including 4281 protein-coding sequences (CDS), 23S rRNA and 16S rRNA. According to the annotation, there are ABC protein channels coding for the transport of nitrate, these genes probably being linked to TCD1-1 T The cells are involved in the uptake and transport of nitrate. In addition, several genes have been identified that are involved in nitrate reduction, including nitrate reductase molybdenum cofactor assembly chaperone proteins, nitrate reductase enzymes (alpha, beta and gamma subunits). Furthermore, strain TCD1-1 T Several cytochrome c reduction and oxidation related enzymes are also encoded. Cytochrome c acts as an electron shuttle, accepting electrons from iron (II), and the reduced cytochrome c releases electrons to nitrate. Therefore, the strain TCD1-1 can be used as a model microorganism of a nitrate-dependent iron oxidation functional microorganism to search for the physiological state of bacteria in a nitrate-dependent iron oxidation process.
Application example is new strain (Enterobacter yingtanensis sp. TCD 1-1) T ) Application of
TCD1-1 T Application and effect of strain NDFO (Newcastle disease Virus) capability
1) Experimental setup
The experiment included a control group (Abiot)ic) and Experimental group (TCD 1-1) T ) Each set is provided with 3 parallels. The culture medium of the experimental group and the first control group is NDFO culture medium. The culture medium of the second control group and the third control group is without NaNO 3 NDFO medium of (1). That is, the culture media in the second control group and the third control group were different from the culture media of the experimental group only in not having NaNO 3 。
The culture conditions were anaerobic and light-proof culture at 30 ℃ for 4 days.
The inoculation source is from a preservation number of CCTCC AB2016351 T The Enterobacter strain TCD1-1 of (9) was cultured on NDFO agar plates (anaerobically cultured at 30 ℃ for 3 days in the absence of light). Colonies were first washed from NDFO agar plates with sterile, anaerobic 0.9% NaCl (w/v) solution, and the cells were washed 3 times (8000 g, 10min) with sterile, anaerobic deionized water and resuspended in 60mL of sterile, anaerobic deionized water. 1mL of TCD1-1 having an OD600 of 1.12 was removed T Cell suspension, to 50mL containing 20mL NDFO medium as experimental group. 1mL of TCD1-1 having an OD600 of 1.12 was removed T Cell suspension to 50mL containing 20mL of NaNO-free 3 The NDFO medium of (c) was used as a second control group.
1mL of sterile, anaerobic, deionized water was removed to 50mL of medium containing 20mL of LNDFO as a first control group. 1mL of sterile, oxygen-free deionized water was pipetted into 50mL of sterile, oxygen-free deionized water containing 20mL of NaNO-free deionized water 3 The NDFO medium of (5) was used as a third control group.
2) Results of the experiment
As shown in fig. 5, fig. 6a to 6c and table 7. In FIG. 5, the left graph is the result obtained after the first control group culture is completed, and the right graph is the result obtained after the experimental group culture is completed. FIG. 6a is the nitrate consumption during 4 days of culture in the experimental group and the first control group. Fig. 6b is the consumption of ferrous iron during 4 days of culture in the experimental group and the first control group. FIG. 6c shows the strain TCD1-1 of the experimental group T Raman spectra of cell surface iron shells after 96 hours of culture in NDFO medium.
TABLE 7 changes in nitrate and ferrous ions during 4 days of culture in the experimental group, the first control group, the second control group and the third control group
As can be seen, during the anaerobic cultivation, strain TCD1-1 of the experimental group was observed in NDFO medium T Brown iron oxides are produced. As shown in Table 7, during the 4-day culture, strain TCD1-1 was present in the experimental group T 1.09mmol L of each of the NDFO media was consumed -1 And 2.44mmol L -1 Nitrate salt of (i) and Fe (II). TCD1-1 T The cells of the strain were coated with iron oxide after 4 days of culture. In the second control group, where no nitrate was added, no oxidation of ferrous ions was observed.
Thus, the accession number is CCTCC AB2016351 T Enterobacter strain TCD1-1 T Has excellent ability to oxidize ferrous iron and reduce nitrate nitrogen, can be used for treatment of sewage and the like, and can be used as a model microorganism for searching the physiological state of bacteria in a nitric acid-dependent iron oxidation process.
Those of ordinary skill in the art will understand that: the discussion of any embodiment above is meant to be exemplary only, and is not intended to intimate that the scope of the disclosure, including the claims, is limited to these examples; within the idea of the present disclosure, also technical features in the above embodiments or in different embodiments may be combined, steps may be implemented in any order, and there are many other variations of the different aspects of the embodiments of the present disclosure as described above, which are not provided in detail for the sake of brevity.
While the present disclosure has been described in conjunction with specific embodiments thereof, many alternatives, modifications, and variations of these embodiments will be apparent to those of ordinary skill in the art in light of the foregoing description.
The disclosed embodiments are intended to embrace all such alternatives, modifications and variances which fall within the broad scope of the appended claims. Therefore, any omissions, modifications, equivalents, improvements, and the like that may be made within the spirit and principles of the embodiments of the disclosure are intended to be included within the scope of the disclosure.
Claims (10)
1. The preservation number is CCTCC AB2016351 T Enterobacter strain TCD1-1 T 。
2. Enterobacter strain TCD1-1 according to claim 1 T The application in ferrous oxidation and nitrate nitrogen reduction.
3. A method for preparing ferrous oxide and reducing nitrate is characterized in that a preservation number of CCTCC AB2016351 is adopted T Enterobacter strain TCD1-1 T Ferrous iron oxidation and nitrate nitrogen reduction.
4. The method of claim 3, wherein the method comprises:
the preservation number is CCTCC AB2016351 T Enterobacter strain TCD1-1 T Inoculating the strain in a first culture medium for culturing and carrying out plate culture;
culturing the Enterobacter strain TCD1-1 T Preparing a cell suspension, and inoculating the cell suspension in a second culture medium for ferrous oxidation and nitrate nitrogen reduction.
5. The method according to claim 4, wherein the pH of the second medium is 6.8-7.2, and the second medium is prepared by adding vitamin solution, trace element solution, selenite-tungstate solution, triethylamine bicarbonate buffer solution, ferrous ions and nitrate into a basic medium; wherein, the concentration ratio of ferrous ions to nitrate ions is 1.
6. The method according to claim 5, wherein the concentration of the ferrous ions is 9.5 to 10.5mmol L -1 The concentration of the nitrate ion is 9.5-10.5 mmol L -1 。
7. The method of claim 5, wherein the first medium is a solid medium, has a pH of 6.8-7.2, and comprises agar and a second medium; the ratio of the mass of the agar to the volume of the second medium is 18-22%.
8. The method according to claim 7, wherein the temperature of the plate culture is room temperature, and the plate culture is carried out in the absence of anaerobic light for 72 hours.
9. The method according to claim 4, wherein the temperature for ferrous oxidation and nitrate nitrogen reduction is room temperature, anaerobic protection from light, 96-120h.
10. The method of claim 4, wherein the OD of the cell suspension is 600 The value was 1.22.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211437811.9A CN115838665B (en) | 2022-11-15 | 2022-11-15 | Enterobacter strain TCD1-1TAnd applications thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211437811.9A CN115838665B (en) | 2022-11-15 | 2022-11-15 | Enterobacter strain TCD1-1TAnd applications thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115838665A true CN115838665A (en) | 2023-03-24 |
CN115838665B CN115838665B (en) | 2024-05-31 |
Family
ID=85577191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211437811.9A Active CN115838665B (en) | 2022-11-15 | 2022-11-15 | Enterobacter strain TCD1-1TAnd applications thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115838665B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102199561A (en) * | 2011-03-21 | 2011-09-28 | 哈尔滨工业大学 | Aerobic denitrifying bacterium treating nitrite as nitrogen source and screening method thereof |
CN108037257A (en) * | 2017-11-23 | 2018-05-15 | 南京大学 | It is a kind of to study test method and the device that iron ion influences Anammox efficiency |
CN109402016A (en) * | 2018-09-21 | 2019-03-01 | 江苏宜裕环保科技有限公司 | For the complex micro organism fungicide of chemical wastewater treatment and its screening and preparation method |
-
2022
- 2022-11-15 CN CN202211437811.9A patent/CN115838665B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102199561A (en) * | 2011-03-21 | 2011-09-28 | 哈尔滨工业大学 | Aerobic denitrifying bacterium treating nitrite as nitrogen source and screening method thereof |
CN108037257A (en) * | 2017-11-23 | 2018-05-15 | 南京大学 | It is a kind of to study test method and the device that iron ion influences Anammox efficiency |
CN109402016A (en) * | 2018-09-21 | 2019-03-01 | 江苏宜裕环保科技有限公司 | For the complex micro organism fungicide of chemical wastewater treatment and its screening and preparation method |
Non-Patent Citations (2)
Title |
---|
MING-JUN LI等: "Underestimation about the Contribution of Nitrate Reducers to Iron Cycling Indicated by Enterobacter Strain", 《MOLECULES》, no. 27, 30 August 2022 (2022-08-30), pages 1 - 13 * |
谢小兰等: "污染河流底泥亚铁氧化硝酸盐还原菌分离及代谢特性", 《中国环境科学》, vol. 35, no. 05, 20 May 2015 (2015-05-20), pages 1554 - 1562 * |
Also Published As
Publication number | Publication date |
---|---|
CN115838665B (en) | 2024-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Flies et al. | Combined approach for characterization of uncultivated magnetotactic bacteria from various aquatic environments | |
Overmann | The family chlorobiaceae | |
Xu et al. | Geomonas oryzae gen. nov., sp. nov., Geomonas edaphica sp. nov., Geomonas ferrireducens sp. nov., Geomonas terrae sp. nov., Four Ferric-Reducing Bacteria Isolated From Paddy Soil, and Reclassification of Three Species of the Genus Geobacter as Members of the Genus Geomonas gen. nov. | |
CN113564081B (en) | Devorax SCS-3 for producing vomitoxin degrading enzyme and application thereof | |
CN109810923B (en) | Aerobic denitrifying bacterium SLY2-21 for sewage denitrification and application thereof | |
CN110283741B (en) | Rose color-changing bacterium with function of efficiently degrading polycyclic aromatic hydrocarbon and application thereof | |
Takai et al. | Hydrogenobacter subterraneus sp. nov., an extremely thermophilic, heterotrophic bacterium unable to grow on hydrogen gas, from deep subsurface geothermal water. | |
CN109897797B (en) | Culture method of sulfate reducing strain, sulfate reducing strain and application | |
CN104371948A (en) | Microbacterium sp. strain and application thereof | |
CN111676165A (en) | Antimony-arsenic-oxidizing pseudomonas and application thereof | |
JP5608725B2 (en) | Novel microorganism, selenate compound reduced preparation, selenate compound reduction method, selenate compound removal method, and metal selenium production method | |
WO2008062557A1 (en) | Novel microorganism capable of microbially decomposing chloro-, methylthio- and methoxy-triazine agrichemicals | |
CN115838665B (en) | Enterobacter strain TCD1-1TAnd applications thereof | |
CN116254207A (en) | Two strains of trichloroethylene assimilation degradation bacteria and application thereof | |
CN116004480A (en) | Deep sea bacteria capable of heterotrophic aerobic growth and having autotrophic sulfur oxidation denitrification function and application thereof | |
CN105670965B (en) | Strain with iron reduction capacity and application thereof | |
WO2009154234A1 (en) | Novel microorganisms, selenium oxide compound reducing agent, method for reducing and method for removing a selenium oxide compound, and process for producing metallic selenium | |
CN111662847B (en) | Enterobacter antimonoroxide and application thereof | |
CN109593673B (en) | Flavobacterium JX-1 and application thereof in sewage treatment | |
CN111826302B (en) | Iron oxidizing bacteria, and application thereof in arsenic-polluted soil remediation, product and method | |
Li et al. | Crassaminicella thermophila sp. nov., a moderately thermophilic bacterium isolated from a deep-sea hydrothermal vent chimney and emended description of the genus Crassaminicella | |
CN113801827A (en) | Acidomyces acidothermus strain and application thereof in leaching copper-containing pollutants of waste circuit boards | |
CN109628355B (en) | Sulfide degrading bacteria and application thereof | |
JP5227673B2 (en) | Novel microorganism, reduced selenate compound preparation, method for reducing and removing selenate compound, and method for producing metal selenium | |
Ten et al. | Lysobacter segetis sp. nov., isolated from soil |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Yang Xiaoru Inventor after: Huang Xinrong Inventor after: Yang Leyang Inventor after: Zhu Yongguan Inventor before: Yang Xiaoru Inventor before: Huang Xinrong Inventor before: Yang Leyang |
|
GR01 | Patent grant | ||
GR01 | Patent grant |